INS and diabetes mellitus: In addition, patients who were prescribed oral antidiabetic agents experienced a significant 34% increase in rate of diabetes progression to insulin therapy associated with ICS therapy.7 Instead, our findings did not reach statistical significance for the comparison between ICS and LABD for diabetes progression, for which post hoc power calculations indicated slightly lower analytical power than for the other comparisons.